A computational study investigates the G161C and Y260C SNP variants of the AGXT protein, which are linked to glyoxylate metabolism. The research explores the potential of tauroursodeoxycholic acid as a therapeutic approach for these deleterious variants.
targeting the highly deleterious g161c and y260c snp variants of the agxt protein involved in glyoxylate metabolism using tauroursodeoxycholic acid a computational study
Original title: “Targeting the Highly Deleterious G161C and Y260C SNP Variants of the AGXT Protein Involved in Glyoxylate Metabolism Using Tauroursodeoxycholic Acid: A Computational Study.”